Overview

Desmopressin as a Therapy for Bedwetting in Children With Sickle Cell Disease

Status:
Terminated
Trial end date:
2018-10-27
Target enrollment:
Participant gender:
Summary
This study assesses if using the medication desmopressin will decrease nightime bedwetting in children with sickle cell disease.
Details
Lead Sponsor:
Montefiore Medical Center
Treatments:
Deamino Arginine Vasopressin